Quantbot Technologies LP Sutro Biopharma, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$3.27 - $5.65 $3,963 - $6,847	-1,212 Reduced 36.59%	2,100 $11,000
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $6,855 - $15,036	3,312 New	3,312 $14,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $43,280 - $64,640	8,000 Added 119.19%	14,712 $118,000
Q3 2022 Nov 07, 2022	BUY	$5.17 - $7.11 $34,701 - $47,722	6,712 New	6,712 $37,000
Q2 2022 Aug 09, 2022	SELL	$3.41 - $8.95 $30,349 - $79,655	-8,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $37,344 - $73,488	4,800 Added 117.07%	8,900 $73,000
Q4 2021 Feb 11, 2022	SELL	$14.25 - $23.53 $9,975 - $16,471	-700 Reduced 14.58%	4,100 $61,000
Q3 2021 Nov 09, 2021	BUY	$16.88 - $22.38 $65,832 - $87,282	3,900 Added 433.33%	4,800 $90,000
Q2 2021 Aug 12, 2021	BUY	$18.03 - $23.82 $16,227 - $21,438	900 New	900 $16,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.